Skip to main navigation Skip to search Skip to main content

Compositional brain scores capture Alzheimer's disease–specific structural brain patterns along the disease continuum

  • Patricia Genius
  • , M. Luz Calle
  • , Blanca Rodríguez-Fernández
  • , Carolina Minguillon
  • , Raffaele Cacciaglia
  • , Diego Garrido-Martin
  • , Manel Esteller
  • , Arcadi Navarro
  • , Alzheimer’s Disease Neuroimaging Initiative
  • , ALFA study
  • Pasqual Maragall Foundation
  • Hospital del Mar
  • The Barcelona Institute of Science and Technology (BIST)
  • The University of Vic - Central University of Catalonia
  • Centro de Investigación Biomédica en Red Sobre Fragilidad y Envejecimiento Saludable
  • University of Barcelona
  • Josep Carreras Leukaemia Research Institute 
  • ICREA
  • Centro de Investigación Biomédica en Red de Cáncer
  • Pompeu Fabra University
  • Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina
  • Centro Nacional de Investigaciones Cardiovasculares Carlos III
  • Radboud University Nijmegen

Research output: Contribution to journalArticleAcademicpeer-review

26 Downloads (Pure)

Abstract

INTRODUCTION: Traditional multivariate methods for neuroimaging studies overlook the interdependent relationship between brain features. This study addresses this gap by analyzing relative brain volumetric patterns to capture how Alzheimer's disease (AD) and genetics influence brain structure along the disease continuum. METHODS: This study analyzed data from participants across the AD continuum from the Alzheimer's and Families (ALFA) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. Compositional data analysis (CoDA) was exploited to examine relative brain volumetric variations that (1) were linked to different AD stages compared to cognitively unimpaired amyloid-β–negative (CU A−) individuals and (2) varied by AD genetic risk. RESULTS: Disease stage–specific compositional brain scores were identified, differentiating CU A− individuals from those in more advanced stages. Genetic risk–stratified models revealed a broader genetic landscape affecting brain morphology in AD, beyond the well-known apolipoprotein E ε4 allele. DISCUSSION: CoDA emerges as an alternative multivariate framework to deepen understanding of AD-related structural changes and support targeted interventions for those at higher genetic risk. Highlights: Compositional data analysis (CoDA) revealed the relative variation of brain region volumes, captured in compositional brain scores, capable of discerning between cognitively unimpaired amyloid-β–negative individuals and subjects within other disease-stage groups along the Alzheimer's disease (AD) continuum. CoDA also uncovered the genetic vulnerability of specific brain regions at each stage of the disease along the continuum. CoDA is capable of integrating magnetic resonance imaging data from two different cohorts without stringent requirements for harmonization. This translates as an advantage, compared to traditional methods, and strengthens the reliability of cross-study comparisons by standardizing the data despite different labeling agreements, facilitating collaborative and large-scale research. The algorithm is sensitive to AD-specific effects, as the main compositional brain scores display little overlap with the age-specific compositional brain score. CoDA provides a more accurate analysis of brain imaging data addressing its compositional nature, which can influence the development of targeted approaches, opening new avenues for enhancing brain health.
Original languageEnglish
Article numbere14490
JournalAlzheimer s & dementia
Volume21
Issue number2
DOIs
Publication statusPublished - 1 Feb 2025
Externally publishedYes

Keywords

  • Alzheimer's disease genetic predisposition
  • brain imaging genetics
  • compositional brain score
  • compositional data analysis
  • multi phenotype analysis
  • neurodegeneration
  • polygenic risk scoring

Fingerprint

Dive into the research topics of 'Compositional brain scores capture Alzheimer's disease–specific structural brain patterns along the disease continuum'. Together they form a unique fingerprint.

Cite this